Clinically, AMH offers a non-invasive, reproducible, and early biomarker for identifying TS patients with preserved ovarian function, enabling more personalized approaches to pubertal induction, hormone replacement, and fertility preservation—particularly valuable in mosaic cases. Here, AMH is linked to Timothy syndrome.